CVNA insider sale: 12,750 shares via option exercise
CVNA Form 144 reports an intended sale of 12,750 common shares by exercise of stock options on 03/02/2026 for cash.
Rhea-AI Filing Summary
CVNA Form 144 reports an intended sale of 12,750 common shares by exercise of stock options on 03/02/2026 for cash. The filing also discloses two prior 10b5-1 sales of 12,750 shares each on 02/02/2026 and 01/02/2026, with proceeds of $5,229,874.60 and $5,138,510.80, respectively.
Positive
- None.
Negative
- None.
Insights
Reported insider sales via option exercise and 10b5-1 plans, with proceeds disclosed.
The filing lists an intended sale of 12,750 common shares on 03/02/2026 arising from an exercise of stock options and identifies two prior 10b5-1 sales of 12,750 shares each on 02/02/2026 and 01/02/2026.
Proceeds for the prior sales are shown as $5,229,874.60 and $5,138,510.80. Timing and mechanism are explicit; cash treatment for the exercise is listed as cash. Subsequent filings may report settlement details or additional trades.
FAQ
What does the CVNA Form 144 disclose about new sales?
What prior insider sales does the CVNA excerpt show?
How much proceeds were reported for the prior CVNA 10b5-1 sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.